hydroxychloroquine has been researched along with Demyelinative Myelitis in 4 studies
Hydroxychloroquine: A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p970)
hydroxychloroquine : An aminoquinoline that is chloroquine in which one of the N-ethyl groups is hydroxylated at position 2. An antimalarial with properties similar to chloroquine that acts against erythrocytic forms of malarial parasites, it is mainly used as the sulfate salt for the treatment of lupus erythematosus, rheumatoid arthritis, and light-sensitive skin eruptions.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Hydroxychloroquine was continued throughout the duration of therapy." | 2.38 | Transverse myelitis complicating systemic lupus erythematosus: treatment including hydroxychloroquine. Case report. ( Klaiman, MD; Miller, SD, 1993) |
| "Transverse myelitis is a rare complication of systemic lupus erythematosus (SLE)." | 1.42 | Systemic lupus erythematosus-associated acute transverse myelitis: manifestations, treatments, outcomes, and prognostic factors in 20 patients. ( Aumaitre, O; Broussolle, C; Cacoub, P; Costedoat-Chalumeau, N; Hot, A; Iwaz, J; Marignier, R; Maucort-Boulch, D; Saison, J; Sarrot-Reynauld, F; Schleinitz, N; Sève, P; Tebib, J; Vital-Durand, D, 2015) |
| "The diagnosis of systemic lupus erythematosus (SLE) was established and even though transverse myelitis as a rare presentation of SLE has a poor outcome, the patient improved with cyclophosphamide, high-dose corticosteroids and hydroxychloroquine." | 1.42 | Lupus or syphilis? That is the question! ( Alves, JD; Duarte, JA; Henriques, CC; Sousa, C, 2015) |
| "A case of transverse myelopathy in systemic lupus erythematosus with subacute onset and fatal course is reported." | 1.26 | [Transverse myelopathy and systemic lupus erythematosus. Report of a case and review of the literature]. ( Borges, TM; de Macedo, DD; de Mattos, JP, 1979) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Saison, J | 1 |
| Costedoat-Chalumeau, N | 1 |
| Maucort-Boulch, D | 1 |
| Iwaz, J | 1 |
| Marignier, R | 1 |
| Cacoub, P | 1 |
| Vital-Durand, D | 1 |
| Hot, A | 1 |
| Tebib, J | 1 |
| Aumaitre, O | 1 |
| Schleinitz, N | 1 |
| Sarrot-Reynauld, F | 1 |
| Broussolle, C | 1 |
| Sève, P | 1 |
| Duarte, JA | 1 |
| Henriques, CC | 1 |
| Sousa, C | 1 |
| Alves, JD | 1 |
| Klaiman, MD | 1 |
| Miller, SD | 1 |
| de Macedo, DD | 1 |
| de Mattos, JP | 1 |
| Borges, TM | 1 |
1 review available for hydroxychloroquine and Demyelinative Myelitis
| Article | Year |
|---|---|
Transverse myelitis complicating systemic lupus erythematosus: treatment including hydroxychloroquine. Case report.
Topics: Adult; Cyclophosphamide; Drug Therapy, Combination; Female; Humans; Hydroxychloroquine; Lupus Erythe | 1993 |
3 other studies available for hydroxychloroquine and Demyelinative Myelitis
| Article | Year |
|---|---|
Systemic lupus erythematosus-associated acute transverse myelitis: manifestations, treatments, outcomes, and prognostic factors in 20 patients.
Topics: Acute Disease; Adrenal Cortex Hormones; Adult; Aged; Anti-Inflammatory Agents; Antirheumatic Agents; | 2015 |
Lupus or syphilis? That is the question!
Topics: Adrenal Cortex Hormones; Cyclophosphamide; Humans; Hydroxychloroquine; Immunosuppressive Agents; Lup | 2015 |
[Transverse myelopathy and systemic lupus erythematosus. Report of a case and review of the literature].
Topics: Adolescent; Demyelinating Diseases; Dexamethasone; Drug Therapy, Combination; Female; Humans; Hydrox | 1979 |